Economic Cost-Benefit Analysis of "Nerve Implanted into Muscle" versus "Targeted Muscle Reinnervation" versus "Regenerative Peripheral Nerve Interface", for Treatment of the Painful Neuroma.

Evaluation of costs and utilities associated with the various surgical options for management of painful neuromas suggest that nerve implantation into muscle is the least expensive option with the best improvement in QALY, while demonstrating comparable outcomes to TMR and RPNI with regards to pain symptoms.